Events and Presentations Presentations Documents January 2023 Corporate Presentation Phase 1/2 study of the oral CCR4 antagonist, FLX475, as monotherapy and in combination with pembrolizumab in advanced cancer, ESMO-IO 2022 September 2022 Corporate Presentation 2022 American Academy of Dermatology (AAD) Annual Meeting Presentation, March 26, 2022 Inflammatory Skin Disease Summit (ISDS) Presentation, November 3, 2021 RPT193 2021 EADV Congress Presentation, September 30, 2021 RAPT Therapeutics RPT193 Phase 1 B Data Presentation RAPT Therapeutics Initial Data Readout for FLX475 FLX475 American Society for Clinical Oncology, May 29, 2020 RPT193 Society for Investigative Dermatology Presentation, May 15, 2020 Upcoming Events There are no upcoming events available at this time.
